WASHINGTON — In a major blow to the effort to pass a federal “right-to-try” law, House Republicans failed to muster the votes to pass a key compromise measure Tuesday.

The legislation was rejected by a vote of 259-140. The bill needed two-thirds majority to pass under suspension of rules.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I am disappointed at such short sighted thinking. Let’s take ALS (Lou Gehrig’s) for example. It has been known to exist since 1824 and is a 100% fatal disease. Ninety percent of afflicted patients die within 48 months of initial diagnosis. Purely on theoretical grounds I am of the opinion that repetitive plasmapheresis will prolong the life of afflicted patients. I make the heretical proposal that a liver transplant may well give an ALS patient a more normal life expectancy. Please see; http://www.Liver-Brain Theory.com

    • I am a stage iv caregiver who has seen first – hand the small , slow , so – called ” compassionate ” use law that RTT opponents defend . 2500 reuqests a year granted by the FDA is pathetically low , and doesn’t tell the story of thousands of pt.’s who cannot get through the bureaucracy. None of the opponents have ever tried to get compassionate use. Someday some of them may have a loved one trying to get one of these life saving drugs. Then they will see….

  • Apparently not a single person who voted against this has a loved-one with a terminal illness. Nor do they have any compassion for dying people who are out of options. My wife is terminally ill. I will make sure I know the names of everyone who voted against this and I will vote accordingly in the future, since reelection is all you really care about. You are killing people with your vote against this. Beautiful, beloved people, like my wife, will die without the chance this legislation could have given them. God have the kind of mercy on your souls that you did not show these dying people.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy